Geneva/New York, July 15, 2026 — Global childhood immunization coverage edged higher in 2025, but progress remains fragile and uneven, with 13.5 million children receiving zero vaccine doses and measles outbreaks...
Summary This prospective case-control study enrolled 258 febrile inpatients and 48 controls at a rural Tanzanian hospital over one year (2023-2024), testing blood by PCR for 35 pathogens, culture, and serology. Measles...
Why We Need a Universal Influenza Vaccine Every year, millions of people roll up their sleeves for a flu shot, and every year, that same shot needs reformulating. This isn’t bureaucratic inefficiency — it’s...
Shigella vaccine breakthrough The live-attenuated oral Shigella sonnei vaccine WRSs2 reported 89% efficacy against shigellosis in a phase 2 controlled human infection trial — the highest protection rate ever recorded...
Summary This narrative review updates the 2021 Global Roadmap for tuberculosis (TB) vaccine research and development, assessing progress across three themes (pipeline diversification, preclinical/clinical acceleration...
1. Five years after the global TB vaccine roadmap launched, progress is real but painfully thin This narrative review updates the 2021 Global Roadmap for tuberculosis (TB) vaccine research and development, assessing...
Ebola virus disease (Bundibugyo, DRC) The Ebola outbreak due to the Bundibugyo virus in the Democratic Republic of the Congo continues to expand and is currently the most significant acute hemorrhagic fever emergency...
India — CDSCO digital submission mandate (effective 1 July) From 1 July 2026, India’s Central Drugs Standard Control Organization (CDSCO) requires that all Post-Approval Change applications for human vaccines and...